FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1985616938> ?p ?o ?g. }

• W1985616938 abstract "Haemophilia is the most serious bleeding model that nature has provided us with, indicating the importance of factor FVIII and FIX in haemostasis. According to current knowledge, haemostasis is initiated by the formation of a complex between tissue factor (TF), exposed as a result of a vessel wall injury, and activated FVII (FVIIa) that is normally present in circulating blood. The TF-FVIIa complexes convert FX into FXa on the TF-bearing cell. FXa then activates prothrombin into thrombin. This limited amount of thrombin activates FVIII, FV, FXI and platelets. Thrombin-activated platelets change shape, resulting in exposure of negatively-charged phospholipids, which form the perfect template for full thrombin generation involving FVIII and FIX. In patients with haemophilia FVIII or FIX is missing. These individuals generate only initial limited amounts of thrombin as its generation is dependent on the presence of FVIII and FIX. Full thrombin generation is necessary for complete activation of FXIII and thrombin activatable fibrinolytic inhibitor to occur. Furthermore, full thrombin generation is important for the fibrin structure of the haemostatic plug. In the case of impaired thrombin generation, fibrin plugs will be loose and highly permeable. Such fibrin plugs are easily dissolved by normal fibrinolytic activity and thus prevent full and maintained haemostasis from occurring. The addition of rFVIIa to FVIII- or FIX-deficient plasma has been shown to increase thrombin generation in a cell-based in vitro model. Furthermore, extra rFVIIa was found to normalise fibrin clot permeability in vitro and to tighten the fibrin structure as studied by three-dimensional confocal microscopy. These findings indicate that administration of rFVIIa is capable of compensating for the lack of FVIII and FIX. Accordingly, the administration of exogenous rFVIIa has been found to stop bleedings in haemophilia patients and, provided it is given in doses high enough, to allow major surgery to be performed in severe haemophiliacs with inhibitors. As rFVIIa enhances thrombin generation on already activated platelets, it has been suggested that rFVIIa may also help to improve haemostasis in other situations involving impaired thrombin generation, such as platelet disorders (thrombocytopenia and functional platelet defects). Preliminary clinical data appear to support this. Patients with profuse bleeding due to extensive surgery or trauma often develop a complex coagulation pattern which includes reduced plasma levels of fibrinogen, FVIII and FV, and decreased platelet counts. These patients may well have an impaired capacity to generate thrombin. Consequently, they may benefit from one or two doses of rFVIIa in order to assist in the generation of a thrombin peak sufficient to form a firm, stable fibrin haemostatic plug and thereby reduce bleeding. This would facilitate any mechanical repair necessary for full haemostasis. Preliminary results in a few patients may support such an effect for rFVIIa. As thrombin has such a crucial role in providing haemostasis, any agent that enhances the thrombin generation in situations with an impaired thrombin formation may be characterised as a 'general haemostatic agent'. Let us look forward to more 'facts' through the 'evidence-based route'." @default.
• W1985616938 created "2016-06-24" @default.
• W1985616938 creator A5085813098 @default.
• W1985616938 date "2002-01-01" @default.
• W1985616938 modified "2023-09-27" @default.
• W1985616938 title "General Haemostatic Agents – Fact or Fiction?" @default.
• W1985616938 cites W1550637983 @default.
• W1985616938 cites W1993430353 @default.
• W1985616938 cites W1996136719 @default.
• W1985616938 cites W2017212158 @default.
• W1985616938 cites W2037652834 @default.
• W1985616938 cites W2046936517 @default.
• W1985616938 cites W2055781719 @default.
• W1985616938 cites W2066001927 @default.
• W1985616938 cites W2069798347 @default.
• W1985616938 cites W2144537409 @default.
• W1985616938 cites W2148505112 @default.
• W1985616938 cites W2239812136 @default.
• W1985616938 cites W2255950219 @default.
• W1985616938 cites W2396194974 @default.
• W1985616938 cites W2407275427 @default.
• W1985616938 cites W2418572926 @default.
• W1985616938 cites W295478337 @default.
• W1985616938 doi "https://doi.org/10.1159/000057299" @default.
• W1985616938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12214145" @default.
• W1985616938 hasPublicationYear "2002" @default.
• W1985616938 type Work @default.
• W1985616938 sameAs 1985616938 @default.
• W1985616938 citedByCount "14" @default.
• W1985616938 countsByYear W19856169382012 @default.
• W1985616938 countsByYear W19856169382015 @default.
• W1985616938 crossrefType "journal-article" @default.
• W1985616938 hasAuthorship W1985616938A5085813098 @default.
• W1985616938 hasBestOaLocation W19856169381 @default.
• W1985616938 hasConcept C126322002 @default.
• W1985616938 hasConcept C141071460 @default.
• W1985616938 hasConcept C144594695 @default.
• W1985616938 hasConcept C185592680 @default.
• W1985616938 hasConcept C186738567 @default.
• W1985616938 hasConcept C203014093 @default.
• W1985616938 hasConcept C2777292125 @default.
• W1985616938 hasConcept C2778382381 @default.
• W1985616938 hasConcept C2778385053 @default.
• W1985616938 hasConcept C2778589496 @default.
• W1985616938 hasConcept C54173615 @default.
• W1985616938 hasConcept C71924100 @default.
• W1985616938 hasConcept C89560881 @default.
• W1985616938 hasConcept C98274493 @default.
• W1985616938 hasConceptScore W1985616938C126322002 @default.
• W1985616938 hasConceptScore W1985616938C141071460 @default.
• W1985616938 hasConceptScore W1985616938C144594695 @default.
• W1985616938 hasConceptScore W1985616938C185592680 @default.
• W1985616938 hasConceptScore W1985616938C186738567 @default.
• W1985616938 hasConceptScore W1985616938C203014093 @default.
• W1985616938 hasConceptScore W1985616938C2777292125 @default.
• W1985616938 hasConceptScore W1985616938C2778382381 @default.
• W1985616938 hasConceptScore W1985616938C2778385053 @default.
• W1985616938 hasConceptScore W1985616938C2778589496 @default.
• W1985616938 hasConceptScore W1985616938C54173615 @default.
• W1985616938 hasConceptScore W1985616938C71924100 @default.
• W1985616938 hasConceptScore W1985616938C89560881 @default.
• W1985616938 hasConceptScore W1985616938C98274493 @default.
• W1985616938 hasLocation W19856169381 @default.
• W1985616938 hasLocation W19856169382 @default.
• W1985616938 hasOpenAccess W1985616938 @default.
• W1985616938 hasPrimaryLocation W19856169381 @default.
• W1985616938 hasRelatedWork W1485311537 @default.
• W1985616938 hasRelatedWork W169620621 @default.
• W1985616938 hasRelatedWork W1739754559 @default.
• W1985616938 hasRelatedWork W18576501 @default.
• W1985616938 hasRelatedWork W1897057798 @default.
• W1985616938 hasRelatedWork W1980229644 @default.
• W1985616938 hasRelatedWork W1998233400 @default.
• W1985616938 hasRelatedWork W2001597437 @default.
• W1985616938 hasRelatedWork W2038005163 @default.
• W1985616938 hasRelatedWork W2040535084 @default.
• W1985616938 hasRelatedWork W2060972622 @default.
• W1985616938 hasRelatedWork W2089322828 @default.
• W1985616938 hasRelatedWork W2110983150 @default.
• W1985616938 hasRelatedWork W2119339335 @default.
• W1985616938 hasRelatedWork W2141465303 @default.
• W1985616938 hasRelatedWork W2429443457 @default.
• W1985616938 hasRelatedWork W2804314752 @default.
• W1985616938 hasRelatedWork W2945768260 @default.
• W1985616938 hasRelatedWork W3031164724 @default.
• W1985616938 hasRelatedWork W963411323 @default.
• W1985616938 isParatext "false" @default.
• W1985616938 isRetracted "false" @default.
• W1985616938 magId "1985616938" @default.
• W1985616938 workType "article" @default.